|
D034
|
|
(−)-Butaclamol hydrochloride solid
|
Dopamine receptor antagonist; less active enantiomer.
|
|
|
|
|
S8010
|
|
(±)-Sulpiride
|
D2 dopamine receptor antagonist; antipsychotic.
|
|
|
|
|
D046
|
|
(+)-Bulbocapnine hydrochloride solid
|
Dopamine receptor antagonist; Water-soluble form of (+)-Bulbocapnine
|
|
|
|
|
D033
|
|
(+)-Butaclamol hydrochloride solid
|
(+)-Butaclamol is a dopamine receptor antagonist; active enantiomer.
|
|
|
|
|
S7771
|
|
(S)-(−)-Sulpiride ≥98% (titration)
|
D2 dopamine receptor antagonist; antipsychotic.
|
|
|
|
|
D043
|
|
(S)-(+)-Apomorphine hydrochloride hydrate solid
|
Dopamine receptor antagonist; inactive as an agonist.
|
|
|
|
|
A7111
|
|
Acepromazine maleate ≥98% (HPLC)
|
Acepromazine is a phenothiazine antipsychotic comonly used as a veterinary drug (horses, dogs and cats). The compound is an analogue antipsychotic drug chlorpromazine (#C8138). The drug is thought to block receptors of dopamine in the brain. Recently it was discover that the compound inhibits ABCG2 transported protein, which overexpression in tumors is associated with drug resistance.
|
|
|
|
|
A2729
|
|
Amisulpride ≥98% (HPLC), solid
|
Amisulpride is a highly selective D2/D3 dopamine receptor antagonist and atypical antipsychotic.
|
|
|
|
|
C1671
|
|
Chlorprothixene hydrochloride
|
D2 dopamine receptor antagonist; blocks a subset of GABAA receptors in rat cortex that is also blocked by clozapine; thioxanthine antipsychotic.
|
|
|
|
|
C6305
|
|
Clozapine
|
Atypical antipsychotic compound. Selective antagonist for D4-dopamine receptor. Antagonist at 5-HT2A, 5-HT2C, 5-HT3, 5-HT6, and 5-HT7 serotonin receptors.
|
|
|
|
|
D122
|
|
Domperidone powder, ≥98% (HPLC)
|
Peripheral dopamine receptor antagonist that does not cross the blood-brain barrier; anti-emetic.
|
|
|
|
|
D1414
|
|
Droperidol
|
D1, D2 dopamine receptor antagonist; butyrophenone antipsychotic and anti-emetic.
|
|
|
|
|
F4429
|
|
FAUC 213 ≥98% (HPLC), solid
|
Highly selective D4 dopamine receptor full antagonist
|
|
|
|
|
F4765
|
|
Fluphenazine dihydrochloride
|
D1/D2 dopamine receptor antagonist; phenothiazine antipsychotic; H1 histamine receptor antagonist.
|
|
|
|
|
F100
|
|
Fluspirilene
|
Dopamine receptor antagonist; antipsychotic; calcium channel blocker.
|
|
|
|
|
G0544
|
|
GR 103691 >98% (HPLC), solid
|
D3 dopamine receptor antagonist.
|
|
|
|
|
H3041
|
|
Halopemide ≥98% (HPLC)
|
Halopemide is a dopamine receptor antagonist and a phospholipase D2 inhibitor. Halopemide may be used as a screen to identify inhibitors of human PLD2 using an in vitro biochemical assay. It is also inhibitory at benzodiazepine binding sites.1
|
|
|
|
|
H1512
|
|
Haloperidol powder
|
Butyrophenone antipsychotic; D2, D3, and D4 dopamine receptor antagonist.
|
|
|
|
|
SML0033
|
|
Itopride hydrochloride ≥98% (HPLC)
|
Itopride is an acetylcholinesterase (AChE) inhibitor and D2 dopamine receptor antagonist. Itopride is used as a gastroprokinetic agent.
|
|
|
|
|
L135
|
|
L-741,626 ≥98% (HPLC), solid
|
Selective D2 dopamine receptor antagonist.
|
|
|
|
|
L131
|
|
L-745,870 hydrochloride
|
Selective D4 dopamine receptor antagonist.
|
|
|
|
|
L133
|
|
L-750,667 trihydrochloride solid
|
Selective D4 dopamine receptor antagonist.
|
|
|
|
|
L8401
|
|
LE 300 solid
|
Potent, selective D1 dopamine receptor antagonist.
|
|
|
|
|
L106
|
|
Loxapine succinate salt solid
|
D2/D4 dopamine receptor antagonist; 5-HT2A/2B, 5-H7 serotonin receptor antagonist; dibenzoxazepine antipsychotic agent.
|
|
|
|
|
M4068
|
|
Mesoridazine benzenesulfonate ≥98% (HPLC), powder
|
Mesoridazine benzenesulfonate is a D2 dopamine receptor antagonist; antipsychotic.
|
|
|
|
|
M0763
|
|
Metoclopramide hydrochloride solid
|
D2 antagonist; 5-HT3 antagonist; antipsychotic; anti-emetic.
|
|
|
|
|
M1818
|
|
Molindone hydrochloride ≥98% (HPLC), solid
|
D2 dopamine receptor antagonist; MAO inhibitor.
|
|
|
|
|
N140
|
|
N-(p-Isothiocyanatophenethyl)spiperone hydrochloride
|
Selective irreversible D2 dopamine receptor antagonist.
|
|
|
|
|
S128
|
|
N-Methylspiperone hydrochloride solid
|
D2 dopamine receptor antagonist.
|
|
|
|
|
SML0066
|
|
NGB 2904 hydrochloride ≥98% (HPLC)
|
NGB 2904 is a potent and selective dopamine D3 receptor antagonist with a D3/D2 ratio of 800 for rat and high binding affinity (1.4 nM) at the hD3 receptor with 150-fold selectivity for primate D3 receptors over primate D2L receptors. It attenuates the rewarding effects of cocaine and methamphetamine.
|
|
|
|
|
O111
|
|
Octoclothepin maleate salt solid
|
D2 dopamine receptor antagonist; 5-HT2 serotonin receptor antagonist.
|
|
|
|
|
SML0018
|
|
PG01037 dihydrochloride hydrate ≥98% (HPLC)
|
PG01037 dihydrochloride is a selective dopamine D3 receptor antagonist. It is more selective for D3 receptors than other D3 antagonists that are currently available with a D2/D3 selectivity ratio of 867and a D4/D3 selectivity ratio of 13,000. Selective dopamine D3 receptor antagonist
|
|
|
|
|
P6402
|
|
Perphenazine
|
D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro.
|
|
|
|
|
P1793
|
|
Pimozide
|
D2 dopamine receptor antagonist; binds with high affinity to the cloned 5-HT7 receptor; Ca2+ channel antagonist; antipsychotic
|
|
|
|
|
P3246
|
|
Pipamperone dihydrochloride ~99% (HPLC), powder
|
D2 dopamine receptor antagonist; 5-HT2 serotonin receptor antagonist; antipsychotic.
|
|
|
|
|
P9178
|
|
Prochlorperazine dimaleate salt
|
Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic
|
|
|
|
|
P6656
|
|
Promazine hydrochloride
|
D2 dopamine receptor antagonist; phenothiazine antipsychotic.
|
|
|
|
|
P7780
|
|
Propionylpromazine hydrochloride
|
Phenothiazine antipsychotic; D2 dopamine receptor antagonist.
|
|
|
|
|
Q3638
|
|
Quetiapine hemifumarate salt ≥98% (HPLC)
|
Quetiapine hemifumarate is an atypical antipsychotic, a combined serotonin (5HT2) and dopamine (D2) receptor antagonist.
|
|
|
|
|
S159
|
|
R(−)-SCH-12679 maleate salt solid
|
D1 dopamine receptor antagonist
|
|
|
|
|
D054
|
|
R(+)-SCH-23390 hydrochloride ≥98% (HPLC), solid
|
R(+)-SCH-23390 hydrochloride is a selective D1 dopamine receptor antagonist.
|
|
|
|
|
D206
|
|
S(−)-DS 121 hydrochloride solid
|
Dopamine autoreceptor antagonist with some selectivity for the D3 dopamine receptor.
|
|
|
|
|
R121
|
|
S(−)-Raclopride (+)-tartrate salt >97%, solid
|
Selective D2 dopamine receptor antagonist.
|
|
|
|
|
D041
|
|
S(+)-Propylnorapomorphine hydrochloride solid
|
Limbic-selective dopamine antagonist.
|
|
|
|
|
E101
|
|
S-(−)-Eticlopride hydrochloride ≥98% (HPLC), powder
|
Potent and selective D2 dopamine receptor antagonist.
|
|
|
|
|
PZ0174
|
|
Sonepiprazole hydrate ≥98% (HPLC)
|
Sonepiprazole (U-101387) is a selective D4 dopamine antagonist. Ki = 10 nM for the dopamine D4.2 receptor.
|
|
|
|
|
S7395
|
|
Spiperone solid
|
Selective D2 dopamine receptor antagonist; α1B-adrenoceptor antagonist; mixed 5-HT2A/5-HT1 serotonin receptor antagonist; antipsychotic.
|
|
|
|
|
T9025
|
|
Thioridazine hydrochloride ≥99%
|
D2 dopamine receptor antagonist; phenothazine antipsychotic with reduced extrapyramidal side effects; Ca2+ channel blocker.
|
|
|
|
|
T0410
|
|
Tiapride hydrochloride
|
D2 and D3 dopamine receptor antagonist; antipsychotic.
|
|
|
|
|
T103
|
|
Trifluperidol hydrochloride
|
Dopamine receptor antagonist; antipsychotic.
|
|
|
|
|
U115
|
|
U-101958 maleate salt solid
|
Selective D4 dopamine receptor antagonist.
|
|
|
|
|
U116
|
|
U-99194 maleate salt ≥98% (HPLC), solid
|
U-99194 is a putative D3 antagonist with a 30-fold preference for the dopamine D3 vs. D2 receptor.
|
|
|
|
|
F114
|
|
cis-(Z)-Flupenthixol dihydrochloride ≥98% (HPLC), solid
|
Antipsychotic; neuroleptic agent; dopamine receptor antagonist.
|
|
|
|